The cascade sign in aquaporin-4-IgG positive (AQP4-IgG+) NMOSD. [PDF]
Bonan L +5 more
europepmc +1 more source
IL-1β contributes to neurological disability in NMOSD AQP4 + Patients. [PDF]
Bruno A +17 more
europepmc +1 more source
Sjögren Syndrome Candidate Autoantigen AQP5 Triggers AQP4 CNS Autoimmunity Through Self-Antigen Mimicry. [PDF]
Moseley CE +9 more
europepmc +1 more source
2025 Brazilian guidelines for the management of neuromyelitis optica spectrum disorder in adults and children. [PDF]
Apóstolos-Pereira SLD +24 more
europepmc +1 more source
Comparative immunoinformatic analysis of Rhipicephalus microplus cocktail vaccine targets. [PDF]
Hendawy SHM, Alzan HF, Ueti MW.
europepmc +1 more source
Tocilizumab in Refractory Neuro Myelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease - Experience from a Tertiary Care Centre. [PDF]
Shaik RS +4 more
europepmc +1 more source
Ravulizumab in NMOSD with associated interstitial pneumonitis in a 59-year-old female patient: a case report. [PDF]
Neundorf A, Dittrich R.
europepmc +1 more source
Correction: RG100204, a novel Aquaporin-9 inhibitor, reduces septic cardiomyopathy and multiple organ failure in murine sepsis. [PDF]
Mohammad S +12 more
europepmc +1 more source

